GlassScriptPhysician profile
Andrew J Young
NPI 1528151305
$1,331.36
in general payments reported to CMS, 2019-2025
29 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.36 · 2020: $445 · 2021: $589 · 2022: $30.71 · 2024: $20.72 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $141.94 | 2025 | Axios |
| E.R. Squibb & Sons, L.L.C. | $139.96 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $93.35 | 2019-2021 | |
| Elekta, INC. | $68.25 | 2021 | |
| Astellas Pharma US INC | $64.78 | 2020 | |
| Celgene Corporation | $57.84 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $57.48 | 2019-2021 | |
| Amgen INC. | $51.37 | 2021 | |
| Karyopharm Therapeutics INC. | $50.48 | 2021 | |
| Janssen Scientific Affairs, LLC | $46.38 | 2020-2024 | Xarelto |
| Emd Serono, INC. | $45.48 | 2020-2021 | |
| Janssen Biotech, INC. | $44.06 | 2020-2021 | |
| Pfizer INC. | $42.44 | 2020-2021 | |
| Daiichi Sankyo INC. | $42.26 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $38.55 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $38.37 | 2021 | |
| Glaxosmithkline, LLC. | $37.53 | 2020-2021 | |
| Incyte Corporation | $36.73 | 2020-2025 | Niktimvo, Jakafi |
| Myovant Sciences INC. | $31.84 | 2021 | |
| Partner Therapeutics, INC. | $24.66 | 2020 | |
| Jazz Pharmaceuticals INC. | $24.25 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.68 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.95 | 2021 | |
| Morphosys, US INC. | $20.79 | 2021 | |
| Kyowa Kirin, INC. | $20.40 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $20.00 | 2021 | |
| Eisai INC. | $19.73 | 2019 | |
| Dova Pharmaceuticals | $15.07 | 2021 | |
| Pharmacosmos Therapeutics INC. | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.